Ayşe Eda Parlak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ayşe Eda Parlak has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Iclal Erdem Toslak
Department of Radiology University of Health Sciences Antalya Training and Research Hospital Antalya Turkey
2 shared publications - Buket Yağcı
Department of Radiology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey
1 shared publication - Burak Yangoz
Department of Radiology, Health Sciences University, Antalya Training and Research Hospital, Antalya 07100, Turkey
1 shared publication Derya Seyman
Infectious Diseases, Health Sciences University Antalya Training and Research Hospital, Antalya, Turkey
1 shared publication- Devrim Toslak
Department of Ophthalmology, Health Sciences University Antalya Training and Research Hospital, Antalya, Turkey
1 shared publication Doğukan Aydenizoz
Otorhinolaryngology
1 shared publication
Latest Publications
- Open Access
- 25 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (11) , 1324
The Significance of Relative Cerebral Blood Volume Index in Discriminating Glial Tumors from Brain Metastasis Using Perfusion Magnetic Resonance Imaging
Background/Objectives: The accurate diagnosis and classification of brain tumors are critical for appropriate treatment planning and patient management. We evaluated the effectiveness of perfusion in differentiating glial tumors from metastases using dynamic susceptibility-weighted contrast enhanced perfusion MRI (DSC-MRI) Methods: A total of 95 consecutive patients with pathological diagnoses of brain tumors who underwent perfusion MRI between July 2021 and March 2023 were retrospectively recruited. Conventional and perfusion MRI were evaluated, and tumoral and peritumoral relative cerebral blood volume (rCBV) values were measured. Mann–Whitney U and Kruskal–Wallis tests were performed for non-parametric comparisons of continuous data. The optimal cut-off value of rCBV in differentiating tumor types was evaluated with the receiver operating characteristic (ROC) curve analysis. Results: Tumoral rCBV (p < 0.001) and peritumoral rCBV values (p = 0.001) were significantly higher in glial tumors than metastases. Further subgroup analyses showed that tumoral and peritumoral rCBV values of glial tumors were higher than those of non-small-cell lung cancers (p < 0.001 and p = 0.003, respectively) and those of breast cancer (p = 0.311 and p = 0.053, respectively) in discriminating high-grade glial tumors and metastases. ROC analyses showed that area under the curve values for tumoral and peritumoral rCBV were 0.816 and 0.725, respectively, for the optimal cut-off points 1.339 and 1.238 (87.5% and 58.33% sensitivity; 73.85% and 90.77% specificity, respectively). Multivariate analysis showed that increased tumoral rCBV and peritumoral rCBV values were independent risk factors for glial tumor occurrence. Conclusions: DSC-MRI is an effective method to differentiate glial tumors and metastases. Higher rCBV values may serve as a determinant for the diagnosis of glial tumors and metastatic brain tumors.
- 25 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (11) , 1324
Open AccessThe Significance of Relative Cerebral Blood Volume Index in Discriminating Glial Tumors from Brain Metastasis Using Perfusion Magnetic Resonance Imaging
Background/Objectives: The accurate diagnosis and classification of brain tumors are critical for appropriate treatment planning and patient management. We evaluated the effectiveness of perfusion in differentiating glial tumors from metastases using dynamic susceptibility-weighted contrast enhanced perfusion MRI (DSC-MRI) Methods: A total of 95 consecutive patients with pathological diagnoses of brain tumors who underwent perfusion MRI between July 2021 and March 2023 were retrospectively recruited. Conventional and perfusion MRI were evaluated, and tumoral and peritumoral relative cerebral blood volume (rCBV) values were measured. Mann–Whitney U and Kruskal–Wallis tests were performed for non-parametric comparisons of continuous data. The optimal cut-off value of rCBV in differentiating tumor types was evaluated with the receiver operating characteristic (ROC) curve analysis. Results: Tumoral rCBV (p < 0.001) and peritumoral rCBV values (p = 0.001) were significantly higher in glial tumors than metastases. Further subgroup analyses showed that tumoral and peritumoral rCBV values of glial tumors were higher than those of non-small-cell lung cancers (p < 0.001 and p = 0.003, respectively) and those of breast cancer (p = 0.311 and p = 0.053, respectively) in discriminating high-grade glial tumors and metastases. ROC analyses showed that area under the curve values for tumoral and peritumoral rCBV were 0.816 and 0.725, respectively, for the optimal cut-off points 1.339 and 1.238 (87.5% and 58.33% sensitivity; 73.85% and 90.77% specificity, respectively). Multivariate analysis showed that increased tumoral rCBV and peritumoral rCBV values were independent risk factors for glial tumor occurrence. Conclusions: DSC-MRI is an effective method to differentiate glial tumors and metastases. Higher rCBV values may serve as a determinant for the diagnosis of glial tumors and metastatic brain tumors.
- 23 September 2024
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 53 (2) , 227-233
Assessing adolescent gynecomastia: The role of shear wave ultrasound elastography
Objectives: Pubertal gynecomastia (PG) is defined as benign proliferation of male breast tissue. Ultrasonography is frequently used for follow‐up of symptomatic gynecomastia. Shear wave elastography (SWE) is an auxiliary tool for the diagnosis of breast disorders. Our aim is to evaluate SWE properties of breast tissue in PG.Methods: Fifty consecutive adolescents, aged 10–18 with a diagnosis of gynecomastia were prospectively included in the study. Following clinical and laboratory evaluation, participants underwent B‐mode ultrasound and classified as nodular, dendritic, and diffuse pattern. SWE and hormonal values of all groups were recorded. Then, statistical analysis was performed.Results: Briefly, 92 breasts (43 left and 49 right; 42 bilateral and 8 unilateral) were included in the analyses. There were no significant differences in clinical parameters including age, BMI‐SDS, estradiol (E2), testosterone (T), and E2/T levels within groups (p > 0.05). Breast volume and SWE levels were significantly different in all groups (p < 0.05). SWE values were significantly lower for those of dendritic pattern than in nodular pattern (p < 0.05). ROC analysis revealed that for the best the cut‐off value of 13.7 kPa, area under the curve value was 0.922 with 84% sensitivity and 87% specificity.Conclusions: SWE values were significantly lower in patients with dendritic gynecomastia than those with nodular gynecomastia. Knowledge of the SWE values for the initial diagnosis and follow‐up values could help avoid unnecessary interventions.
- 23 September 2024
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 53 (2) , 227-233
Assessing adolescent gynecomastia: The role of shear wave ultrasound elastography
Objectives: Pubertal gynecomastia (PG) is defined as benign proliferation of male breast tissue. Ultrasonography is frequently used for follow‐up of symptomatic gynecomastia. Shear wave elastography (SWE) is an auxiliary tool for the diagnosis of breast disorders. Our aim is to evaluate SWE properties of breast tissue in PG.Methods: Fifty consecutive adolescents, aged 10–18 with a diagnosis of gynecomastia were prospectively included in the study. Following clinical and laboratory evaluation, participants underwent B‐mode ultrasound and classified as nodular, dendritic, and diffuse pattern. SWE and hormonal values of all groups were recorded. Then, statistical analysis was performed.Results: Briefly, 92 breasts (43 left and 49 right; 42 bilateral and 8 unilateral) were included in the analyses. There were no significant differences in clinical parameters including age, BMI‐SDS, estradiol (E2), testosterone (T), and E2/T levels within groups (p > 0.05). Breast volume and SWE levels were significantly different in all groups (p < 0.05). SWE values were significantly lower for those of dendritic pattern than in nodular pattern (p < 0.05). ROC analysis revealed that for the best the cut‐off value of 13.7 kPa, area under the curve value was 0.922 with 84% sensitivity and 87% specificity.Conclusions: SWE values were significantly lower in patients with dendritic gynecomastia than those with nodular gynecomastia. Knowledge of the SWE values for the initial diagnosis and follow‐up values could help avoid unnecessary interventions.
- 6 September 2024
- Published by Springer Nature in Die Radiologie
- Vol. 64 (S1) , 153-159
Evaluation of carotid intima-media thickness measurements in patients with central serous chorioretinopathy
Background Central serous chorioretinopathy (CSC) is a systemic disease more than a disease localized to the eye, and there may be vascular involvement in its pathogenesis. Objective This study aimed to evaluate the carotid intima-media thickness (IMT) of patients with CSC, to compare it with that of healthy individuals, and to explore whether there might be an association between CSC and subclinical carotid atherosclerotic disease. Materials and methods Adult patients with CSC (n = 30) and healthy individuals (n = 30) were included in this prospective study. All participants underwent complete ophthalmologic imaging and were then referred to the radiology department. Carotid IMT measurements were performed using ultrasound imaging. Measurements of the two groups were obtained and compared. Results There was no statistically significant difference between patients with CSC and the control group with respect to age, gender, and smoking habits. The mean (±standard deviation, SD) carotid IMT values obtained by ultrasound measurements for the right and left sides in the patient group were 0.71 mm (± 0.19) and 0.71 mm (± 0.21), respectively. The mean (±SD) carotid IMT values for the right and left sides in the control group were 0.61 mm (± 0.15) and 0.60 mm (± 0.15), respectively. The mean carotid IMT values in the patient group were significantly higher than those in the control group for the right and left sides (p = 0.02 and p = 0.03, respectively). Conclusion Carotid IMT is increased in patients with CSC compared to healthy individuals. This outcome might reinforce the benefit of carotid artery screening following diagnosis of CSC by ophthalmologists for early detection of subclinical carotid atherosclerotic disease. Graphic abstract
- 6 September 2024
- Published by Springer Nature in Die Radiologie
- Vol. 64 (S1) , 153-159
Evaluation of carotid intima-media thickness measurements in patients with central serous chorioretinopathy
Background Central serous chorioretinopathy (CSC) is a systemic disease more than a disease localized to the eye, and there may be vascular involvement in its pathogenesis. Objective This study aimed to evaluate the carotid intima-media thickness (IMT) of patients with CSC, to compare it with that of healthy individuals, and to explore whether there might be an association between CSC and subclinical carotid atherosclerotic disease. Materials and methods Adult patients with CSC (n = 30) and healthy individuals (n = 30) were included in this prospective study. All participants underwent complete ophthalmologic imaging and were then referred to the radiology department. Carotid IMT measurements were performed using ultrasound imaging. Measurements of the two groups were obtained and compared. Results There was no statistically significant difference between patients with CSC and the control group with respect to age, gender, and smoking habits. The mean (±standard deviation, SD) carotid IMT values obtained by ultrasound measurements for the right and left sides in the patient group were 0.71 mm (± 0.19) and 0.71 mm (± 0.21), respectively. The mean (±SD) carotid IMT values for the right and left sides in the control group were 0.61 mm (± 0.15) and 0.60 mm (± 0.15), respectively. The mean carotid IMT values in the patient group were significantly higher than those in the control group for the right and left sides (p = 0.02 and p = 0.03, respectively). Conclusion Carotid IMT is increased in patients with CSC compared to healthy individuals. This outcome might reinforce the benefit of carotid artery screening following diagnosis of CSC by ophthalmologists for early detection of subclinical carotid atherosclerotic disease. Graphic abstract
- 24 November 2023
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 48 (2) , 317-322
Olfactory Bulb Volume and Morphology Changes in COVID-19 Patients With Olfactory Disorders Using Magnetic Resonance Imaging
Objectives: The aims of the study are to explore the morphological changes of olfactory bulb (OB) and olfactory sulcus in COVID-19 patients with associated olfactory dysfunction (OD) by measuring the OB volume (OBV) and olfactory sulcus depth (OSD) and to compare the measurement values with those of healthy individuals. Methods: Between March 2020 and January 2022, 31 consecutive hospitalized patients with a diagnosis of COVID-19 with anosmia and hyposmia who underwent brain magnetic resonance imaging and 35 normosmic control individuals were retrospectively included in the study. Bilateral OBV and OSD were measured and shape of the OB was determined based on the consensus by a neuroradiologist and an otorrhynolaryngologist. Results: The mean measurements for the right and the left sides for OBV (38 ± 8.5 and 37.1 ± 8.4, respectively) and OSD (7.4 ± 0.1 and 7.4 ± 1.0 mm, respectively) were significantly lower in COVID-19 patients with OD than those in control group (for the right and the left sides mean OBV 56.3 ± 17.1 and 49.1 ± 13.5, respectively, and mean OSD 9.6 ± 0.8 and 9.4 ± 0.8 mm, respectively). Abnormally shaped OB (lobulated, rectangular, or atrophic) were higher in patient group than those of controls. For the optimal cutoff values, OBV showed sensitivity and specificity values of 90.32% and, 57.14%, for the right, and 87.1% and 62.86% for the left side, respectively (area under the curve, 0.819 and 0.780). Olfactory sulcus depth showed sensitivity and specificity values of 90.32% and 94.29%, for the right, and 96.77% and 85.71%, for the left side, respectively (area under the curve, 0.960 and 0.944). Conclusions: Decrease in OBV and OSD measurements in COVID-19 patients with OD at the early chronic stage of the disease supports direct damage to olfactory neuronal pathways and may be used to monitor olfactory nerve renewal while returning back to normal function.
- 24 November 2023
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 48 (2) , 317-322
Olfactory Bulb Volume and Morphology Changes in COVID-19 Patients With Olfactory Disorders Using Magnetic Resonance Imaging
Objectives: The aims of the study are to explore the morphological changes of olfactory bulb (OB) and olfactory sulcus in COVID-19 patients with associated olfactory dysfunction (OD) by measuring the OB volume (OBV) and olfactory sulcus depth (OSD) and to compare the measurement values with those of healthy individuals. Methods: Between March 2020 and January 2022, 31 consecutive hospitalized patients with a diagnosis of COVID-19 with anosmia and hyposmia who underwent brain magnetic resonance imaging and 35 normosmic control individuals were retrospectively included in the study. Bilateral OBV and OSD were measured and shape of the OB was determined based on the consensus by a neuroradiologist and an otorrhynolaryngologist. Results: The mean measurements for the right and the left sides for OBV (38 ± 8.5 and 37.1 ± 8.4, respectively) and OSD (7.4 ± 0.1 and 7.4 ± 1.0 mm, respectively) were significantly lower in COVID-19 patients with OD than those in control group (for the right and the left sides mean OBV 56.3 ± 17.1 and 49.1 ± 13.5, respectively, and mean OSD 9.6 ± 0.8 and 9.4 ± 0.8 mm, respectively). Abnormally shaped OB (lobulated, rectangular, or atrophic) were higher in patient group than those of controls. For the optimal cutoff values, OBV showed sensitivity and specificity values of 90.32% and, 57.14%, for the right, and 87.1% and 62.86% for the left side, respectively (area under the curve, 0.819 and 0.780). Olfactory sulcus depth showed sensitivity and specificity values of 90.32% and 94.29%, for the right, and 96.77% and 85.71%, for the left side, respectively (area under the curve, 0.960 and 0.944). Conclusions: Decrease in OBV and OSD measurements in COVID-19 patients with OD at the early chronic stage of the disease supports direct damage to olfactory neuronal pathways and may be used to monitor olfactory nerve renewal while returning back to normal function.
- Open Access
- 3 November 2022
- Published by The European Research Journal in The European Research Journal
- Vol. 8 (6) , 882-891
Comparison of apparent diffusion coefficient and relative apparent diffusion coefficient values for differential diagnosis of breast lesions
Objectives: The purpose the study was to evaluate the role of diffusion weighted magnetic resonance imaging (DW-MRI) in diagnosis of benign and malignant breast lesions, to calculate a cut-off apparent diffusion coefficient (ADC) value and to explore use of relative ADC (r ADC) for improving sensitivity and specificity of MRI in diagnosis of breast cancer. Methods: This retrospective study based on a cohort of patients who underwent dynamic contrast enhanced (DCE)-MRI having suspicious breast mass by ultrasonography and mammography to whom DWI sequence was added to the routine diagnostic MRI. ADC and r ADC (lesion/normal breast tissue) values of breast masses were calculated. The threshold ADC values used to differentiate benign and malignant lesions were determined using receiver operating characteristic analysis, sensitivity, specificity, positive predictive value and negative predictive value were calculated. Results: Malignant masses had significantly lower ADC (mean: 1.03 ± 0.36 × 10-3 mm2/s) and r ADC (mean: 0.66 ± 0.22 × 10-3 mm2/s) values than those of benign masses with ADC (mean: 1.50 ± 0.56 × 10−3 mm2/s) and r ADC (mean: 0.97 ± 0.31 × 10-3 mm2/s) values, respectively (p = 0.001 for both). The best cut-off value for the lesion ADC was 1.09 × 10-3 mm2/s with a sensitivity of 72.73%, and specificity of 79.17%. The best cut-off value for r ADC was 0.83 with sensitivity of 78.79% and specificity of 70.83%. Conclusions: DWI has high diagnostic value with high sensitivity and specificity differentiating benign and malignant breast lesions. ADC and r ADC values can improve the diagnostic accuracy of differentiating benign and malignant breast lesions.
- 3 November 2022
- Published by The European Research Journal in The European Research Journal
- Vol. 8 (6) , 882-891
Open AccessComparison of apparent diffusion coefficient and relative apparent diffusion coefficient values for differential diagnosis of breast lesions
Objectives: The purpose the study was to evaluate the role of diffusion weighted magnetic resonance imaging (DW-MRI) in diagnosis of benign and malignant breast lesions, to calculate a cut-off apparent diffusion coefficient (ADC) value and to explore use of relative ADC (r ADC) for improving sensitivity and specificity of MRI in diagnosis of breast cancer. Methods: This retrospective study based on a cohort of patients who underwent dynamic contrast enhanced (DCE)-MRI having suspicious breast mass by ultrasonography and mammography to whom DWI sequence was added to the routine diagnostic MRI. ADC and r ADC (lesion/normal breast tissue) values of breast masses were calculated. The threshold ADC values used to differentiate benign and malignant lesions were determined using receiver operating characteristic analysis, sensitivity, specificity, positive predictive value and negative predictive value were calculated. Results: Malignant masses had significantly lower ADC (mean: 1.03 ± 0.36 × 10-3 mm2/s) and r ADC (mean: 0.66 ± 0.22 × 10-3 mm2/s) values than those of benign masses with ADC (mean: 1.50 ± 0.56 × 10−3 mm2/s) and r ADC (mean: 0.97 ± 0.31 × 10-3 mm2/s) values, respectively (p = 0.001 for both). The best cut-off value for the lesion ADC was 1.09 × 10-3 mm2/s with a sensitivity of 72.73%, and specificity of 79.17%. The best cut-off value for r ADC was 0.83 with sensitivity of 78.79% and specificity of 70.83%. Conclusions: DWI has high diagnostic value with high sensitivity and specificity differentiating benign and malignant breast lesions. ADC and r ADC values can improve the diagnostic accuracy of differentiating benign and malignant breast lesions.